biomark
continu
sought
fi
eld
diagnost
microbiolog
laboratori
diagnosi
assess
microbi
infect
set
clinic
laboratori
criteria
necessari
ideal
diagnost
marker
infect
previous
propos
ng
colleagu
accord
criteria
ideal
biomark
possess
minimum
follow
characterist
biochem
biomark
stabl
remain
signi
fi
cantli
deregul
bodi
fl
uid
compart
least
h
even
commenc
appropri
treatment
may
allow
adequ
time
window
specimen
collect
storag
without
signi
fi
cant
decomposit
activ
compound
laboratori
process
b
concentr
determin
quantit
method
measur
automat
rapid
easi
inexpens
c
collect
specimen
minim
invas
requir
small
volum
eg
ml
blood
numer
biomark
found
test
clinic
practic
current
microrna
mirna
molecul
without
doubt
biomark
greatest
potenti
capac
diagnost
microbiolog
fi
eld
fi
rst
mirna
inadvert
discov
caenorhabd
elegan
lee
colleagu
howev
recognit
mirna
abil
regul
ruvkun
colleagu
result
establish
new
class
regulatori
nucleic
acid
potenti
valu
diagnost
microbiolog
major
character
mirna
intergen
locat
intron
primari
mirna
transcript
ie
primirna
transcrib
rna
polymeraseii
iii
nucleu
ribonucleas
drosha
cleav
primirna
releas
stemloop
intermedi
structur
name
premirna
premirna
transport
cytoplasm
protein
cleav
dicer
rnase
iii
form
matur
doublestrand
mirna
one
strand
mirna
duplex
subsequ
unwound
incorpor
effector
protein
complex
term
rnainduc
silenc
complex
risc
respons
gene
silenc
posttranscript
manner
matur
mirna
singlestrand
rna
molecul
nucleotid
length
partial
homolog
untranscrib
region
utr
target
mrna
mirna
control
gene
express
via
repress
translat
well
reduc
mrna
level
directli
larg
number
mirna
found
variou
anim
plant
tissu
accord
mirbas
http
micrornasangerorg
collect
registri
current
known
mirna
sequenc
target
host
sanger
institut
current
recogn
mirna
sequenc
homo
sapien
genom
number
constantli
grow
new
mirna
sequenc
discov
recent
virusencod
mirna
discov
mirna
may
function
control
viral
replic
thu
limit
antivir
respons
inhibit
apoptosi
stimul
cellular
growth
moreov
uniqu
host
cell
mirna
express
pro
fi
le
reveal
respons
variou
microbi
infect
host
mirna
appear
play
role
viral
replic
may
use
host
cell
control
viral
infect
begin
mirna
found
circul
serum
plasma
well
bodi
fl
uid
saliva
tear
urin
mirna
appear
enrich
speci
fi
c
fl
uid
circul
mirna
subsequ
becom
focu
ongo
research
properti
origin
function
relationship
diseas
circul
mirna
intens
explor
number
import
observ
note
circul
mirna
present
stabl
form
protect
endogen
rnase
activ
group
also
report
higher
stabil
mirna
compar
mrna
sampl
obtain
formalinfi
xed
paraf
fi
nembed
tissu
express
level
mirna
note
consist
among
individu
speci
express
alter
circul
mirna
report
associ
pathophysiolog
state
includ
variou
cancer
heart
diseas
pregnanc
diabet
needless
say
serum
plasma
bodi
fl
uid
specimen
gener
avail
clinic
test
pro
fi
ling
hundr
mirna
requir
l
sera
thu
uniqu
stabl
characterist
circul
mirna
potenti
make
extrem
use
biomark
diseas
diagnosi
prognosi
fi
rst
virusencod
mirna
describ
pfeffer
colleagu
identi
fi
ed
fi
epsteinbarr
viru
ebv
encod
premirna
sinc
hundr
virusencod
mirna
describ
human
anim
plant
exampl
human
virusencod
mirna
shown
tabl
bewilderingli
virusencod
mirna
known
today
herpesviru
origin
moreov
almost
virusencod
mirna
encod
dna
virus
except
encod
retrovirus
reversetranscrib
integr
genet
materi
host
dna
aberrantli
express
circul
mirna
explor
diagnosi
prognosi
sever
infecti
diseas
includ
sepsi
hbv
hcv
viral
mirna
target
perfectli
complementari
viral
mrna
well
imperfectli
complementari
viral
andor
cellular
mrna
viral
mirna
modul
express
host
gene
involv
cell
prolifer
surviv
stress
respons
antivir
defens
pathway
pivot
viral
replic
anoth
primari
function
viru
mirna
regul
latentlyt
switch
latenc
host
cell
accumul
amount
evid
demonstr
virusencod
mirna
mediat
evolutionarili
conserv
function
eg
immun
evas
cell
cycl
control
promot
latenc
etc
mirna
show
poorli
primari
sequenc
conserv
phenomena
rais
import
question
viral
mirna
use
detect
maker
viru
infect
latent
infect
phase
despit
fact
littl
viral
protein
produc
studi
need
evalu
hypothesi
microbi
infect
known
downmodul
least
cellular
mrna
therebi
exert
physiolog
effect
microbi
infect
induc
chang
host
mirna
express
pro
fi
le
may
also
profound
effect
outcom
infect
host
mirna
may
directli
indirectli
affect
viru
replic
pathogenesi
exampl
liverspeci
fi
c
requir
hcv
replic
moreov
overexpress
rest
lymphocyt
compar
activ
counterpart
mirna
abl
target
sequenc
near
portion
mrna
fi
nding
suggest
mirna
may
contribut
viral
latenc
howev
unclear
whether
mirna
activ
inhibit
viral
factor
whether
deregul
due
host
respons
host
mirna
express
pro
fi
le
note
repres
speci
fi
c
pathophysiolog
state
theoret
characterist
pro
fi
le
potenti
biomark
diseas
diagnosi
prognosi
number
studi
conduct
demonstr
theori
promis
result
seen
number
alter
physiolog
state
includ
variou
cancer
heart
diseas
pregnanc
diabet
injuri
infect
use
mirna
pro
fi
le
infect
diseas
discuss
next
section
houzet
colleagu
pro
fi
led
mirna
peripher
blood
mononuclear
cell
pbmc
infect
patient
found
cell
abund
mirna
downregul
threeto
ninefold
compar
cell
uninfect
control
depend
diseas
stage
patient
triloubet
et
al
report
increas
express
mirna
includ
infect
jurkat
cell
wherea
express
polycistron
mirna
cluster
compris
strongli
decreas
like
human
cell
leukemia
viru
type
also
infect
cell
two
mirnapro
fi
ling
studi
perform
infect
cell
line
atl
adult
tcell
leukemia
cell
studi
fi
nd
two
common
mirna
consist
downregul
context
infect
mirna
express
pro
fi
le
bronchoalveolar
stem
cell
basc
infect
sar
coronaviru
cov
determin
use
mirna
microarray
total
mirna
found
differenti
express
upregul
basc
coopt
sarscov
suppress
replic
evad
immun
elimin
success
transmiss
take
place
contrast
viral
nucleocapsid
spike
protein
target
seem
coopt
downregul
respect
differenti
express
mirna
chicken
lung
trachea
infect
low
pathogen
strain
avian
fl
uenza
viru
analyz
deep
sequenc
approach
total
mirna
differenti
express
lung
trachea
upon
viru
infect
respect
lung
cellular
micrornaom
mice
infect
reconstruct
fl
uenza
viru
compar
mice
infect
nonleth
season
fl
uenza
viru
group
microrna
includ
differenti
express
respons
fl
uenza
viru
infect
infect
two
fl
uenza
virus
induc
distinct
microrna
express
pro
fi
le
previous
analyz
mirna
express
pro
fi
le
adenoviru
type
infect
human
laryng
epitheli
cell
use
solid
deep
sequenc
total
mirna
demonstr
high
express
mirna
show
lower
express
infect
cell
control
cell
wang
et
al
monitor
time
cours
cellular
mirna
express
human
cytomegaloviru
cmv
infect
cell
use
mirna
microarray
fortynin
mirna
signi
fi
cantli
chang
least
one
time
point
global
unidirect
chang
chang
mirna
sometim
transient
cluster
recent
found
downregul
cmvinfect
cell
infect
human
primari
neural
cell
high
phenotyp
reactiv
herp
simplex
induc
upregul
brainenrich
microrna
mirna
also
found
highli
upregul
kaposi
sarcoma
ks
associ
herpesviru
kshv
etiolog
agent
ks
type
protein
kshv
induc
express
microrna
via
conserv
motif
strongli
stimul
upregul
ebv
oncogen
herp
viru
endem
human
also
found
patient
diffus
larg
bcell
lymphoma
dlbcl
ebv
de
novo
infect
primari
cultur
human
bcell
result
dramat
downregul
cellular
mirna
express
mirna
detect
downregul
averag
downregul
imig
et
al
found
express
upregul
downregul
twofold
due
ebvinfect
dlbcl
cameron
et
al
demonstr
differenti
express
cellular
mirna
type
iii
versu
type
ebv
latenc
includ
elev
express
b
contrast
express
found
lower
type
iii
latenc
vitro
infect
assay
reveal
helicobact
pylori
infect
affect
mirna
express
pro
fi
le
speci
fi
calli
mirna
signi
fi
cantli
upregul
human
gastric
epitheli
cell
infect
recent
express
pattern
mirna
gastric
mucosa
infect
h
pylori
use
endoscop
biopsi
specimen
determin
microarray
differenti
express
mirna
h
pylori
infect
uninfect
mucosa
twofold
mirna
express
pro
fi
ling
could
distinguish
h
pylori
statu
eight
mirna
yield
accept
sensit
speci
fi
citi
musclespeci
fi
c
mirna
signi
fi
cantli
downregul
stomach
longterm
infect
h
pylori
mous
model
schult
et
al
identi
fi
ed
differenti
regul
mirna
compar
deep
sequenc
total
cdna
librari
prepar
small
rna
popul
host
cell
salmonella
infect
mocktreat
cell
murin
raw
cell
upregul
observ
infect
also
observ
signi
fi
cant
downregul
sever
famili
member
name
hela
cell
signi
fi
cant
upregul
mirna
salmonella
limit
contrast
remain
unaffect
intriguingli
downregul
mirna
also
occur
hela
cell
sharbati
et
al
perform
mirna
well
mrna
express
analysi
human
monocytederiv
macrophag
infect
sever
mycobacterium
avium
hominissui
strain
use
microarray
well
qrtpcr
found
express
increas
respons
mycobacteri
infect
h
express
signi
fi
cantli
reduc
human
papillomaviru
hpv
infect
hpv
infect
downregul
express
accur
determin
mirna
express
level
speci
fi
c
cell
tissu
fl
uid
prerequisit
assess
biolog
patholog
clinic
role
health
diseas
theoret
mrna
detect
method
use
mirna
analysi
howev
follow
characterist
mirna
sequenc
make
quanti
fi
cation
mirna
express
technic
challeng
first
matur
mirna
short
nucleotid
nt
mirna
within
famili
may
differ
singl
nucleotid
make
dif
fi
cult
design
speci
fi
c
primer
probe
reliabl
amplifi
label
mirna
without
introduc
signal
bia
second
mirna
heterogen
gc
content
result
melt
temperatur
tm
nucleic
acid
duplex
vari
wide
final
target
sequenc
present
primari
mirna
transcript
primirna
precursor
mirna
premirna
matur
mirna
therefor
import
ensur
nonact
primirna
premirna
precursor
speci
contribut
detect
signal
sever
standard
method
quanti
fi
cation
mrna
level
success
adapt
mirna
includ
northern
blot
clone
situ
hybrid
rtpcr
microarray
addit
emerg
techniqu
base
colorimetr
fl
uoresc
bioluminesc
enzym
electrochem
hold
immens
promis
futur
mirna
detect
howev
technic
issu
must
address
accept
among
current
standard
method
northern
blot
fi
rst
techniqu
use
detect
mirna
consid
gold
standard
character
mirna
express
basic
procedur
mirna
northern
blot
similar
tradit
blot
done
follow
small
rna
molecul
separ
use
high
percentag
denatur
ureaacrylamid
gel
rather
usual
agaros
electrophoresi
gel
b
small
rna
molecul
transfer
gel
onto
membran
c
mirna
molecul
fi
xed
membran
variou
crosslink
procedur
membran
hybrid
radiolabel
oligonucleotid
probe
northern
blot
method
abl
determin
absolut
amount
mirna
sampl
blot
dilut
seri
synthet
oligo
mirna
molecul
known
concentr
parallel
sampl
concentr
mirna
sampl
calcul
standard
curv
obtain
dilut
seri
howev
short
length
well
low
preval
matur
mirna
molecul
lead
poor
sensit
routin
northern
analysi
requir
larg
amount
total
rna
sampl
gener
g
disadvantag
method
includ
low
throughput
potenti
environ
hazard
radiolabel
sever
technic
modi
fi
cation
use
improv
detect
sensit
lna
lock
nucleic
acid
modi
fi
ed
oligonucleotid
probe
increas
af
fi
niti
lna
probe
target
mirna
result
least
tenfold
increas
sensit
use
solubl
carbodiimid
crosslink
method
increas
ef
fi
cienci
mirna
fi
xed
membran
increas
mirna
detect
sensit
compar
tradit
uv
crosslink
method
wide
use
method
detect
quali
fi
cation
mirna
appear
realtim
quantit
rtpcr
qrtpcr
small
size
matur
mirna
sequenc
well
sequenc
homolog
matur
precursor
mirna
form
limit
direct
applic
convent
rtpcr
protocol
mirna
detect
solv
problem
innov
solut
appli
step
qrtpcr
use
quantit
analysi
mirna
fi
rst
step
qrtpcr
mirna
accur
complet
convers
mirna
cdna
two
differ
approach
revers
transcript
mirna
report
fi
rst
approach
mirna
revers
transcrib
individu
use
mirnasspeci
fi
c
revers
transcript
primer
stemloop
appli
biosystem
co
fig
linear
primer
exiqon
fig
contain
partial
complementari
sequenc
end
mirna
anneal
mirna
order
prime
revers
transcript
doubl
strand
structur
stemloop
primer
prevent
nonspeci
fi
c
bind
preand
primirna
therebi
increas
speci
fi
citi
assay
unlik
stemloop
primer
design
linear
primer
simpler
linear
primer
discrimin
matur
mirna
precursor
anoth
approach
done
follow
mirna
fi
rst
tail
adenosin
nucleotid
end
mirna
poli
polymeras
fig
linker
adaptor
rna
ligas
fig
primer
consist
oligo
dt
sequenc
univers
primerbind
sequenc
end
univers
primer
complementari
end
linker
use
prime
revers
transcript
univers
revers
primer
sequenc
introduc
cdna
revers
transcript
design
mirna
speci
fi
c
forward
primer
critic
speci
fi
citi
sensit
qrtpcr
assay
lna
modi
fi
cation
wide
use
method
increas
tm
speci
fi
citi
primer
incorpor
lna
monom
increas
tm
depend
upon
posit
lna
moieti
oligonucleotid
primer
two
approach
avail
detect
qrtpcr
product
one
approach
use
sybr
green
dye
whose
fl
uoresc
increas
approxim
upon
intercal
dsdna
chain
properti
use
monitor
real
time
ampli
fi
cation
product
accumul
pcr
reaction
one
limit
sybr
greenbas
method
target
pcr
product
nonspeci
fi
c
product
discrimin
therefor
melt
point
analysi
usual
requir
follow
pcr
ampli
fi
cation
reach
use
duallabel
hydrolysi
taqman
probe
basi
type
taqman
probe
detect
review
bene
castoldi
characterist
taqman
mirna
assay
make
ideal
suit
detect
matur
mirna
moreov
taqman
mirna
assay
discrimin
relat
mirna
differ
primer
consist
oligo
dt
sequenc
univers
primerbind
sequenc
end
c
univers
primer
complementari
end
linker
use
prime
revers
transcript
one
nucleotid
howev
cost
taqman
probe
higher
sybr
green
method
limit
routin
use
laboratori
qrtpcr
method
demonstr
high
sensit
speci
fi
citi
abil
accur
detect
mirna
singl
stem
cell
low
amount
start
materi
rang
nanogram
total
rna
need
quantit
result
acquir
within
h
method
also
consider
larger
dynam
rang
compar
microarray
analysi
recent
qrtpcr
techniqu
adapt
increas
throughput
develop
mirna
pcr
array
detect
hundr
mirna
one
reaction
tube
exampl
includ
taqman
low
densiti
microrna
array
tlda
appli
biosystem
mirna
pcr
array
sabiosci
qiagen
compani
anoth
wide
use
highthroughput
techniqu
analysi
express
level
mirna
molecul
microarray
technolog
microarray
technolog
fi
rstli
appli
mirna
studi
sinc
numer
approach
base
differ
microarray
platform
develop
mirna
quanti
fi
cation
basic
procedur
mirna
quanti
fi
cation
use
microarray
platform
includ
mirna
probe
design
array
prepar
b
isol
mirna
label
c
hybrid
signal
detect
schemat
fl
ow
chart
mirna
pro
fi
ling
microarray
shown
fig
design
microrna
probe
isol
microrna
sampl
label
mirna
critic
procedur
mirna
microarray
assay
short
length
mirna
make
design
probe
dif
fi
cult
design
probe
almost
exclus
determin
sequenc
mirna
sequenc
mirna
determin
wider
tm
distribut
probe
therefor
tm
normal
full
set
probe
absolut
requir
sinc
hybrid
usual
carri
one
temperatur
solv
problem
two
techniqu
lna
util
adjust
length
probe
success
use
normal
tm
valu
quantiti
mirna
also
import
mirna
microarray
assay
sinc
abund
mirna
total
rna
low
rel
larg
amount
mirna
need
comparison
rtpcr
assay
convent
denatur
ureaacrylamid
gel
electrophoresi
combin
commerci
kit
eg
microrna
isol
kit
ambion
inc
microrna
isol
kit
invitrogen
co
demonstr
excel
ef
fi
cienci
isol
mirna
label
mirna
absolut
key
step
overal
sensit
microarray
mani
method
develop
label
mirna
classi
fi
ed
two
main
categori
direct
label
indirect
label
direct
label
fl
uoresc
dye
accomplish
enzymat
current
use
method
includ
label
poli
polymeras
label
though
rna
ligas
guanin
label
label
microrna
rnaprim
arraybas
klenow
enzym
assay
rake
fluoresc
dye
also
conjug
adjac
oh
matur
mirna
use
chemic
reagent
indirect
label
method
includ
label
mirna
revers
transcript
rtpcr
product
mirna
vitro
transcript
mirna
advantag
indirect
label
obviou
sinc
revers
transcript
product
mirna
stabl
easi
preserv
addit
mirna
ampli
fi
ed
label
synchron
pcr
vitro
transcript
use
lowabund
mirna
although
direct
label
simpl
method
inher
problem
includ
fact
guanin
label
suitabl
mirna
lack
g
residu
ligas
label
introduc
base
bia
procedur
chemic
label
somewhat
complic
though
indirect
label
sensit
method
may
introduc
arti
fi
cial
error
ligat
pcr
ampli
fi
cation
procedur
anoth
microarray
techniqu
use
biotin
label
mirna
hybrid
lan
probe
coupl
xmap
suspens
microspher
luminex
co
offer
rapid
reproduc
result
solid
planar
array
due
favor
reaction
kinet
liquid
phase
use
techniqu
singl
nt
differ
discrimin
microarray
technolog
proven
standard
techniqu
pro
fi
ling
mirna
express
nextgener
sequenc
ng
also
call
massiv
parallel
deep
sequenc
becom
effect
method
mirna
analysi
sequenc
throughput
ng
unapproach
mirna
analysi
techniqu
sinc
lay
dna
fragment
singl
chip
simultan
sequenc
million
fragment
parallel
principl
ng
describ
chapter
book
elsewher
current
three
main
platform
widespread
use
mirna
pro
fi
ling
discoveri
roch
gs
flx
sequenc
illumina
genom
analyz
appli
biosystem
solid
sequenc
methodolog
ng
mirna
analysi
similar
includ
srna
isol
librari
prepar
sequenc
data
analysi
addit
increas
throughput
ng
techniqu
signi
fi
cantli
reduc
clone
bias
observ
tradit
capillari
sequenc
sinc
sequenc
read
gener
fragment
librari
need
clone
ampli
fi
ed
anoth
key
advantag
ng
microarray
mirna
studi
pro
fi
le
unknown
gene
sinc
sequenc
speci
fi
c
probe
need
detect
current
novel
mirna
discov
character
ng
ng
also
gaug
mirna
express
level
count
clone
frequenc
demonstr
sensit
microarray
one
disadvantag
ng
comprehens
pro
fi
le
mrna
express
techniqu
rather
expens
compar
microarray
though
cost
signi
fi
cantli
decreas
develop
commerci
platform
anoth
limit
ng
read
length
rel
short
bp
compar
tradit
capillari
sequenc
bp
limit
use
de
novo
assembl
complet
genom
make
becom
ideal
instrument
mirna
pro
fi
ling
sinc
length
mirna
nucleotid
shorter
read
length
ng
describ
techniqu
mirna
detect
advantag
disadvantag
method
use
best
fi
research
goal
experiment
condit
exampl
new
mirna
discoveri
identi
fi
cation
addit
sequenc
techniqu
clone
mirna
may
simplest
method
situ
hybrid
suitabl
locat
mirna
tissu
northern
blot
sensit
timeconsum
practic
larg
clinic
studi
routin
detect
express
hundr
mirna
qrtpcr
abl
detect
low
copi
number
high
sensit
speci
fi
citi
studi
express
level
multimirna
simultan
microarray
sequenc
may
best
choic
anoth
import
problem
although
platform
rel
stabl
term
microrna
pro
fi
ling
intrareproduc
interplatform
reproduc
among
differ
platform
low
industri
standard
analysi
mirna
express
await
advanc
technolog
comput
although
alter
mirna
express
pro
fi
le
detect
variou
tissu
cell
follow
microbi
infect
pro
fi
le
yet
use
biomark
clinic
practic
obtain
infect
tissu
cell
dif
fi
cult
without
invas
procedur
describ
circul
mirna
serumplasma
seem
suitabl
biomark
easili
use
diagnosi
prognosi
infect
potenti
use
discuss
next
section
diagnosi
monitor
sepsi
dif
fi
cult
mani
sign
symptom
caus
noninfecti
disord
current
gold
standard
diagnos
septicemia
blood
cultur
gener
take
sever
day
longer
earli
biomark
sepsi
investig
includ
acut
phase
protein
creactiv
protein
cytokin
tnfa
chemokin
gcsf
procalcitonin
metabonom
date
biomark
demonstr
suf
fi
cient
sensit
andor
speci
fi
citi
guid
clinic
manag
host
mirna
express
pro
fi
le
intens
studi
use
vitro
vivo
model
fl
ammat
trigger
escherichia
coli
lipopolysaccharid
lp
stimul
exampl
express
increas
human
acut
monocyt
leukemia
cell
line
respons
lp
stimul
upregul
downregul
observ
human
monocytederiv
dendrit
cell
ceppi
et
al
schmidt
et
al
screen
differenti
express
mirna
circul
leukocyt
use
vivo
model
acut
fl
ammat
also
trigger
lp
found
four
mirna
downregul
one
upregul
vasilescu
et
al
pro
fi
led
genomewid
mirna
microarray
peripher
blood
leukocyt
sepsi
patient
found
express
pro
fi
le
differenti
sepsi
patient
healthi
control
moreov
level
signi
fi
cantli
reduc
plasma
sampl
sepsi
patient
correl
level
diseas
sever
final
investig
note
plasma
level
ratio
use
assess
sever
sepsi
recent
wang
et
al
analyz
seven
mirna
express
level
patient
diagnos
sepsi
system
fl
ammatori
respons
syndrom
sir
healthi
control
use
qrtpcr
assay
determin
serum
signi
fi
cantli
reduc
septic
patient
compar
sir
patient
healthi
control
area
receiv
oper
characterist
curv
respect
hbv
infect
also
known
modul
express
host
cellular
mirna
particip
develop
hbvrelat
liver
diseas
mirna
pro
fi
le
chronic
hepat
b
patient
tissu
hbvexpress
cell
review
liu
et
al
li
et
al
pro
fi
led
serum
mirna
healthi
control
hbv
hcv
hbvposit
hepatocellular
carcinoma
hcc
affect
individu
solexa
sequenc
follow
valid
quantit
rtpcr
assay
investig
success
identi
fi
ed
mirna
differenti
express
hbv
serum
biomark
accur
discrimin
hbv
case
control
hcv
case
also
hbvposit
hcc
case
control
hbv
case
exampl
use
four
marker
separ
control
hbv
group
auc
sensit
speci
fi
citi
similarli
two
marker
could
separ
control
hcv
group
high
speci
fi
citi
sensit
auc
sensit
speci
fi
citi
control
hbvposit
hcc
group
could
clearli
separ
marker
auc
sensit
speci
fi
citi
similarli
hbv
hbvposit
hcc
group
could
separ
two
marker
auc
sensit
speci
fi
citi
anoth
studi
pro
fi
led
mirna
express
pool
sera
obtain
identi
fi
ed
group
chronic
asymptomat
carrier
asc
patient
chronic
hepat
b
chb
hbvassoci
acuteonchron
liver
failur
aclf
well
healthi
control
hc
use
appli
biosystem
taqmanarray
assay
total
mirna
ampli
fi
ed
hc
wherea
ampli
fi
ed
asc
chb
aclf
respect
express
level
mirna
also
upregul
hbvinfect
patient
compar
hc
furthermor
level
mirna
chb
serum
upregul
hepat
b
e
antigenposit
patient
express
abund
mirna
liver
tissu
signi
fi
cantli
higher
hbv
infect
group
hc
express
similar
hc
asc
increas
signi
fi
cantli
chb
aclf
express
level
correl
neg
age
patient
chb
aclf
vitro
acut
hcv
infect
model
human
mirna
identi
fi
ed
whose
express
level
chang
respons
hcv
infect
marquez
et
al
measur
level
hcvinfect
human
liver
biopsi
rel
uninfect
human
liver
correl
clinic
patient
data
found
express
correl
viral
load
fi
brosi
serum
liver
transaminas
level
express
invers
correl
fi
brosi
liver
transaminas
level
patient
age
morita
et
al
describ
hepat
express
weakli
posit
correl
serum
hcv
load
correl
hcv
load
human
liver
bihrer
et
al
found
sera
patient
chronic
hcv
infect
contain
higher
level
sera
healthi
control
serum
level
correl
well
marker
liver
fl
ammatori
activ
serum
level
alanin
leucin
transaminas
alt
aspart
transaminas
histolog
activ
index
hai
score
patient
persist
normal
alt
level
serum
level
differ
healthi
control
correl
serum
level
serum
albumin
intern
normal
ratio
liver
fi
brosi
serum
hcv
rna
thu
serum
appear
act
biomark
necroin
fl
ammat
patient
chronic
hepat
c
infect
previous
perform
comprehens
mirna
pro
fi
ling
cell
use
deep
sequenc
total
mirna
found
whose
express
level
chang
twofold
respons
infect
ho
et
al
found
upregul
upon
enteroviru
infect
facilit
viral
propag
expedit
translat
switch
recent
compar
host
serum
mirna
level
patient
handfootandmouth
diseas
caus
enteroviru
coxsackieviru
well
microbi
infect
healthi
individu
among
differ
mirna
analyz
use
mirna
array
upregul
downregul
sera
patient
enterovir
infect
express
level
ten
candid
mirna
evalu
quantit
realtim
pcr
assay
receiv
oper
characterist
roc
curv
analysi
reveal
six
mirna
abl
discrimin
patient
enteroviru
infect
healthi
control
area
curv
auc
valu
rang
combin
six
mirna
use
multipl
logist
regress
analysi
provid
sensit
speci
fi
citi
also
uniqu
pro
fi
le
differenti
enterovir
infect
microbi
infect
express
level
fi
mirna
signi
fi
cantli
increas
patient
versu
p
combin
possess
moder
abil
discrimin
auc
valu
data
indic
sera
patient
differ
subtyp
enterovir
infect
express
uniqu
mirna
pro
fi
le
serum
mirna
express
pro
fi
le
may
provid
supplement
biomark
diagnos
subtyp
enterovir
handfootandmouth
diseas
infect
circul
mirna
investig
diagnosi
prognosi
marker
microbi
infect
studi
host
mirna
pro
fi
le
upon
microbi
infect
underway
consider
way
go
use
clinic
practic
sever
issu
fi
ned
fi
eld
sourc
materi
fi
xed
plasma
serum
whole
blood
isol
exosom
microvesicl
use
sourc
mirna
pro
fi
ling
advantag
disadvantag
approach
consid
ahead
b
though
differ
circul
mirna
male
femal
found
except
differ
associ
pregnanc
mirna
level
plasma
serum
larg
number
normal
individu
gender
variou
age
even
individu
time
extens
studi
c
acknowledg
refer
gene
found
serumplasma
frequent
use
endogen
control
dysregul
diseas
degrad
serum
spike
rna
isol
process
synthet
exogen
mirna
act
normal
differ
recoveri
sampl
method
mirna
quanti
fi
cation
includ
rna
isol
standard
sinc
interplatform
reproduc
among
differ
platform
low
e
seem
lack
speci
fi
citi
use
singl
mirna
biomark
sinc
mirna
commonli
regul
variou
diseas
panel
mirna
best
choic
